Veea Inc. (NASDAQ: VEEA) gets $14.1M NLabs loan, ends bank line

Rhea-AI Filing Summary

Veea Inc. entered into a new unsecured loan with principal stockholder NLabs Inc. on January 5, 2026. NLabs lent Veea $14,100,000 under a Demand Promissory Note bearing 10% annual interest, with all principal and interest due on the earlier of March 31, 2026 or whenever NLabs demands repayment. Veea may repay the note early at any time without penalty.

Veea used the loan proceeds to repay in full its line of credit with JP Morgan Chase. The company paid the bank $14,076,218, covering all outstanding principal and interest as of January 5, 2026, and the line of credit and all related commitments were terminated.

Insights

Corporate finance analyst

Veea replaces bank credit line with short-term related-party loan.

Veea obtained an unsecured Demand Promissory Note from principal stockholder NLabs Inc. for $14,100,000 at a 10% annual interest rate. The note is due on the earlier of March 31, 2026 or on demand by NLabs, which means the timing of repayment can change quickly based on the lender’s decision.

The company immediately used the proceeds to repay its JP Morgan Chase line of credit in full, paying $14,076,218 and terminating that facility and all commitments. This shifts Veea’s main short-term financing from a bank to a major stockholder affiliated with its CEO, concentrating credit exposure in a single related party while eliminating the bank line.

false 0001840317 0001840317 2026-01-05 2026-01-05 0001840317 VEEA:CommonStockParValue0.0001PerShareMember 2026-01-05 2026-01-05 0001840317 VEEA:WarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember 2026-01-05 2026-01-05 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 8, 2026 (January 5, 2026)

Veea Inc.

(Exact name of registrant as specified in its charter)

Delaware		001-40218		98-1577353
(State or other Jurisdiction of Incorporation)		(Commission  File Number)		(IRS Employer Identification No.)

164 E. 83rd Street

New York, NY 10028

(212) 535-6050

(Address and telephone number, including area code, of registrant’s principal executive offices)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common stock, par value $0.0001 per share		VEEA		The Nasdaq Stock Market LLC
Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50 per share		VEEAW		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 1.01 Entry into a Material Definitive Agreement.

On January 5, 2026, NLabs Inc, a Delaware corporation (“NLabs”) made an unsecured loan to Veea Inc., a Delaware corporation (the “Company”). NLabs is a principal stockholder of the Company and an affiliate of the Company’s Chief Executive Officer. The loan was in the principal amount of $14,100,000 and evidenced by a Demand Promissory Note (the “Note”). Interest on the Note accrues and is payable at maturity at an annual rate equal to 10%, with interest calculated on the basis of a 365-day year and the actual days elapsed. The Note and accrued interest thereon is payable upon the earlier of March 31, 2026 and demand by NLabs. The Company may prepay the Note, in whole or in part, without penalty at any time. The proceeds of the Note were used by the Company to repay its existing line of credit facility with JP Morgan Chase Bank. The material terms of the repayment of the line of credit are summarized under Item 1.02 of this Current Report on Form 8-K.

Item 1.02 Termination of a Material Definitive Agreement.

On January 5, 2026, Veea Inc., a Delaware corporation (the “Company”), repaid in full its line of credit (the “Line of Credit”) with JP Morgan Chase (the “Bank”) by making a cash payment to the Bank of $14,076,218, representing the total outstanding principal and interest due as of January 5, 2026. In connection with the repayment, the Line of Credit and all commitments thereunder were terminated. Repayment of the Line of Credit was made with the proceeds of a loan made to the Company by NLabs Inc, a Delaware corporation (“NLabs”). The material terms of the loan are summarized under Item 1.01 of this Current Report on Form 8-K.

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

The information set forth above under Item 1.01 of this Current Report on Form 8-K with respect to the issuance of the Note to NLabs is hereby incorporated by reference into this Item 2.03.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits. The following exhibits are filed with this Form 8-K:

Exhibit Number		Description
1.01*		Demand Promissory Note dated January 5, 2026
104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Veea Inc.
Date: January 8, 2026	By:	/s/ Allen Salmasi
	Name:	Allen Salmasi
	Title:	Chief Executive Officer

2

FAQ

What did Veea Inc. (VEEA) disclose in this 8-K filing?

Veea Inc. reported that it received an unsecured $14,100,000 loan from principal stockholder NLabs Inc. and used the proceeds to fully repay and terminate its JP Morgan Chase line of credit.

How large is the new NLabs loan to Veea Inc. (VEEA)?

The new unsecured Demand Promissory Note from NLabs to Veea has a principal amount of $14,100,000.

What are the key terms of Veea’s loan from NLabs?

The NLabs loan to Veea is unsecured, bears 10% annual interest, and all principal and interest are payable on the earlier of March 31, 2026 or demand by NLabs. Veea may prepay it at any time without penalty.

How did Veea Inc. use the proceeds from the NLabs loan?

Veea used the loan proceeds to repay in full its JP Morgan Chase line of credit, making a cash payment of $14,076,218 representing all outstanding principal and interest as of January 5, 2026.

What happened to Veea’s JP Morgan line of credit?

After paying JP Morgan Chase $14,076,218, Veea’s line of credit and all commitments under that facility were terminated.

Who is NLabs in relation to Veea Inc. (VEEA)?

NLabs Inc. is described as a principal stockholder of Veea Inc. and an affiliate of the company’s Chief Executive Officer.